Why the study?
Does contemporary treatment improve the prognosis and natural history of hypertrophic cardiomyopathy compared to historical management?
Does contemporary treatment improve the prognosis and natural history of hypertrophic cardiomyopathy compared to historical management?
Contemporary treatments have substantially improved the prognosis of hypertrophic cardiomyopathy, reducing annual mortality to less than 1%.
No takes yet. Share an insight, caveat, or question.
Contemporary management may improve HCM survival; extends observational data but leaves open need for prospective validation.
Autore et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: